Modelling the role of immunity in reversion of viral antigenic sites

DOI10.1101/027995MaRDI QIDQ327141zbMATH OpenOpenAlexWikidataFDO

Authors Carmen H. S. Chan, Lloyd P. Sanders, Mark M. Tanaka

Publication date 19 October 2016

Published in Journal of Theoretical Biology (Search for Journal in Brave)

Copyright license Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International

Full work available at URL https://doi.org/10.1101/027995

zbMATH Keywords

epidemiological modelviral evolutionantigenic selectionback mutationcost of escape

Mathematics Subject Classification ID

Epidemiology (92D30) Genetics and epigenetics (92D10) Problems related to evolution (92D15)

Recommendations

• ICIAM/GAMM 95 Applied Analysis
• Antigenic distance and cross-immunity, invasibility and coexistence of pathogen strains in an epidemiological model with discrete antigenic space
• A model for pathogen population structure with cross-protection depending on the extent of overlap in antigenic variant repertoires
• A sparse hierarchical Bayesian model for detecting relevant antigenic sites in virus evolution
• Some basic properties of immune selection

Cites work

• Estimating variability in models for recurrent epidemics: assessing the use of moment closure techniques
• Modeling infectious diseases in humans and animals
• The mathematics of infectious diseases
• The size of epidemics in populations with heterogeneous susceptibility

Cited in

(6)

• Model for comparative analysis of antigen receptor repertoires
• Immune Responses against Conserved and Variable Viral Epitopes
• A sparse hierarchical Bayesian model for detecting relevant antigenic sites in virus evolution
• A minimal model of T cell avidity may identify subtherapeutic vaccine schedules
• The importance of vaccinated individuals to population-level evolution of pathogens
• Do rhinoviruses follow the neutral theory? The role of cross-immunity in maintaining the diversity of the common cold

This page was built for publication: Modelling the role of immunity in reversion of viral antigenic sites

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q327141)